Crescent Biopharma, Inc. (CBIO) stock
CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$12.40−0.64 (-4.91%)
Close on Nov 18, 2026Market cap $460.58MP/E –Yield –
Crescent Biopharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Crescent Biopharma's price to sales ratio was 430.9× on Feb 29, 2016.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Feb 29, 2016 | 430.9× | −43.2 |
| 2014 | Apr 30, 2014 | 474.1× | – |
See a number that looks wrong?